Cronos Group Inc. Stock Analysis & AI Score
Cronos Group Inc. (CRON) has an ST Score of 64.4 (B), driven by its Financial Strength (A+) and held back by its Valuation (C-). Analysts rate it Hold with a $3.15 price target (-4.0% downside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AICRON Stock Price History
CRON Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
CRON Latest Stock News
ST Score
Cronos Group Inc. (CRON) has an ST Score of 64.4 (B), driven by its Financial Strength (A+) and held back by its Valuation (C-). Analysts rate it Hold with a $3.15 price target (-4.0% downside).
- Strongest
- Financial StrengthA+
- Weakest
- ValuationC-
All factor grades
- Financial StrengthA+
- SentimentA+
- ProfitabilityA
- MomentumB+
- GrowthC+
- ForecastC+
- ValuationC-
- Piotroski5/9
Press Releases
Company Contact Details
CRON stock: frequently asked questions
What is CRON's ST Score?
Cronos Group Inc. (CRON) has an ST Score of 64.4 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CRON a buy, hold, or sell?
Analysts rate CRON a Hold, with a price target of $3.15 (-4.0% vs the current price). Our ST Score grades it B (64.4/100). The ST Score is a data-driven signal, not a recommendation.
What are CRON's factor grades?
Valuation C-, Profitability A, Financial Strength A+, Momentum B+, Growth C+, Forecast C+, Sentiment A+.
What is CRON's valuation grade?
Cronos Group Inc. (CRON) earns a valuation grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CRON's growth grade?
Cronos Group Inc. (CRON) earns a growth grade of C+, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CRON's profitability grade?
Cronos Group Inc. (CRON) earns a profitability grade of A, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CRON's financial strength grade?
Cronos Group Inc. (CRON) earns a financial strength grade of A+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for CRON?
The average analyst price target for Cronos Group Inc. (CRON) is $3.15 from 15 analysts, which is -4.0% versus the recent price of $3.28.
What is CRON's Piotroski score?
Cronos Group Inc. (CRON) has a Piotroski F-Score of 5 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.